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ABSTRACT: Macrophages play a key role in determining the fate
of implanted biomaterials, especially for biomaterials such as
calcium phosphates (CaPs) where these cells play a vital role in
material resorption and osteogenesis, as shown in different models,
including clinical samples. Although substantial consideration is
given to the design and validation of different CaPs, relatively little
is known about their material−cell interaction. Specifically, the
intracellular content of different CaP phases remains to be
assessed, even though CaP-filled macrophages have been observed
in several studies. In this study, 2D/3D ToF-SIMS imaging and
multivariate analysis were directly applied on the histology samples
of an explant to reveal the content of macrophages. The cellular
content of the macrophages was analyzed to distinguish three CaP phases, monetite, beta-tricalcium phosphate, and pyrophosphate,
which are all part of the monetite-based CaP implant composition under study. ToF-SIMS combined with histology revealed that
the content of the identified macrophages was most similar to that of the pyrophosphate phase. This study is the first to uncover
distinct CaP phases in macrophages from a human multiphasic CaP explant by targeted direct cell content analysis. The uncovering
of pyrophosphate as the main phase found inside the macrophages is of great importance to understand the impact of the selected
material in the process of biomaterial-instructed osteogenesis.
KEYWORDS: calcium phosphate, pyrophosphate, cranial implant, macrophages, ToF-SIMS
1. INTRODUCTION
Calcium phosphates (CaPs) remain as the synthetic bio-
materials of choice for bone regeneration and repair1−7 owing
to their chemical homology with the inorganic part of the bone
and the ability to promote bone formation while slowly
degrading.1−7,8
The CaP material degradation is achieved via mechanical
breakdown, passive chemical dissolution, or active cell-
mediated resorption via macrophages, monocytes, multi-
nucleated giant cells, and osteoclasts.9−13 While the material
degradation gradually occurs, osteoblasts are attracted to the
region and initiate bone formation. Osteoblasts synthesize and
secrete the bone matrix and deposit calcium to form new bone.
The newly formed bone is resorbed by osteoclasts (bone
modeling), shaping the bone and ensuring its optimal
function.12,14
During material-mediated bone formation and regeneration,
macrophages and their main precursor, monocytes, are among
the first cells attracted to the implant.15−20 Macrophages are
known as “true” phagocytes responsible for the internalization
and subsequent digestion of exogenous and endogenous
contents.15,20,21 Even though CaP-filled macrophages have
been observed in various in vivo models following months to
years after implantation,1,2,4,6,22−25 the nature of the content
engulfed still lacks substantial evidence. Given that macro-
phages have been suggested to play an important role in
biomaterial-instructed osteogenesis, studying their interaction
with various CaP phases might yield valuable insights into the
underlying mechanism of action.16,17,26,27
Time-of-flight secondary ion mass spectrometry (ToF-
SIMS) has previously been used to detect lipids and organic
materials at implant surfaces to characterize calcium phosphate
phases in powders28,29 and at implant surfaces and interfaces to
ascertain inorganic information from calcium- and phosphate-
containing materials.30−32 Additionally, the high lateral
resolution of ToF-SIMS allows for intracellular information
to be obtained.33−35
In order to identify the content of macrophages, we aimed to
evaluate if ToF-SIMS could be employed to characterize the
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macrophage content concerning three CaP phases, monetite,
beta-tricalcium phosphate (β-TCP), and beta-calcium pyro-
phosphate (β-CPP), in a clinically retrieved titanium-
reinforced CaP cranial implant 31 months after implantation.
2. EXPERIMENTAL SECTION
2.1. Material Production and Characterization. Four different
CaP compositions were synthesized for the experiment: beta-calcium
pyrophosphate (β-CPP) produced by decomposing di-calcium
phosphate dihydrate (DCPD, brushite, Acros Organics) at 1100
°C; beta-tricalcium phosphate (β-TCP) prepared through a solid−
state reaction of a powder mixture of brushite (Acros Organics) and
calcium carbonate (Acros Organics) at 1100 °C; brushite synthesized
by mixing at a L/P ratio of 0.22 a 50:50 mixture of monocalcium
phosphate monohydrate (MCPM, Scharlau):β-TCP (Degradable
Solutions AG) with a citric acid aqueous solution (0.5 M), which
was set in water for 24 h and then dried at room temperature; and
monetite obtained by autoclaving the abovementioned brushite; a
CaP mixture of the implant was fabricated by mixing MCPM with a
mixture of β-TCP and β-CPP as pre-mixed cements.22
The phase compositions of the different calcium phosphates were
ascertained through X-ray diffraction (XRD; Aeris Panalytical,
Malvern for Monetite, β-TCP, and β-CPP and D8 Advance, Bruker
AXS GmbH for implant calcium phosphate composition) with a
theta−theta (2θ) setup with Ni-filtered Cu−K irradiation. Rietveld
refinements were applied to perform a quantitative phase composition
analysis. BGMN software (www.bgmn.de) was used with Profex as
the user interface.36 Crystalline models were taken from the Profex
database based on literature references for β-CPP (PDF# 04-009-
3876),37 β-TCP (PDF# 04-010-4348),38 and monetite (PDF# 04-
009-3755).39 No other phases were identified in the diffraction
patterns.
2.2. Sample Processing. 2.2.1. Clinical Retrieval. A 30-year-old
woman was diagnosed with osseous sphenoidal wing meningioma in
November 2014 and subsequently underwent tumor resection and
cranial reconstruction with a titanium-reinforced CaP implant
(OssDsign Cranial PSI). A period of 31 months after implantation,
the implant was explanted due to tumor progression into the orbit,
which required surgical intervention. Except for the tumor, the patient
is in good general condition with no immunodeficiency. The patient
provided signed informed consent, and the review was conducted
under Regional Ethics Committee approval, Stockholm Dnr 2017/
251031.
2.3. Sample Evaluation. 2.3.1. Computed Tomography (CT).
The subject’s post-operative and follow-up CT scans (Discovery
CT750 HD, GE Healthcare, Wisconsin, USA) were reviewed in terms
of implant remodeling and bone formation.
2.3.2. Histology. 2.3.2.1. Histological Processing. The cranial
sample was preserved in 10% neutral buffered paraformaldehyde at
the time of explantation. The implant was later dehydrated in alcohol
solutions of increasing concentration (60, 80, 95%, and 2× 99.9%)
and cleared in xylene. The material samples and the cranial implant
were infiltrated in increasing concentration of resin, using the
Technovit 7200 (Kulzer Exakt, Histolab, Gothenburg Sweden),
mixed with 99.9% ethanol in steps of 30:70, 50:50, 7:30, 100, and
100%. Histological sections were prepared using a microcutting and
microgrinding system (EXAKT System, Advanced Technologies
GmbH, Germany), with the thickness of each section ranging
between 15 and 35 μm. Prior to staining, the section was immersed in
30% H2O2 (Sigma-Aldrich, Stockholm, Sweden) for 6 min to etch the
surface of the specimens and then immersed in 12% acetic acid for 30
s to decalcify the surface slightly. Thereafter, the section was stained
for 30 min with modified Paragon consisting of 0.01% Toluidine Blue
O and 0.02% borax in distilled water. Subsequently, the slide was
exposed to 0.005% basic fuchsine in 95% ethanol for 30 s and finally
with 0.1% Safranin O in distilled water for 5 min. Between all steps of
pretreating and staining, the slide was rinsed in tap water twice and
wiped dry. All stains and solutions were obtained from Histolab,
Gothenburg Sweden.
2.3.2.2. Analysis. Histological analysis was performed to identify
macrophages, osteoblast cells, osteoclasts, osteocytes, red blood cells
and blood vessels, newly formed bone, and adipose tissue by two
expert pathologists from different institutions (Karolinska Institute
and NAMSA) before and after staining with modified Paragon.
Images were observed and captured using a 40× objective under an
optical microscope.
2.4. TOF-SIMS. The different CaP phases (β-CPP, β-TCP, and
monetite) and samples of human tissue cranial explants were analyzed
with ToF-SIMS on a TOF.SIMS 5 instrument (ION-TOF GmbH,
Münster, Germany) equipped with a Bismuth-cluster ion gun as the
primary ion source and a C60 ion source for sputtering and depth
profiling. Different fields of view (n = 5) ranging from 60 × 60 to 500
× 500 μm were analyzed in the two-dimensional (2D) mode with the
following settings: pulsed primary ion beam (Bi3
+, 0.34 pA at 25 keV),
the so-called high-bunched mode,40 a focus of approximately 2 μm,
and a mass resolution of approx. M/ΔM = 5000 fwhm at m/z 500.
Selected areas were also analyzed in 2D with the delayed extraction
mode41 with a focus of approx. 400 nm and an achieved mass
resolution of approx.M/ΔM = 4000 fwhm at m/z 500. The maximum
ion dose density of Bi3
+ was kept at 2 × 1011 ions cm−2 and therefore
below that of the static limit, that is, 1 × 1013 ions cm−2, to avoid
causing surface damage to allow subsequent histological analysis.
Three-dimensional (3D) imaging and depth profiling was
performed with the pulsed Bi3
+ gun (0.34 pA) and a 20 keV C60
2+
beam with a current of 0.2 nA in the non-interlaced mode. The ion
dose for C60
2+ ranged from 1 × 1014 to 9 × 1014 ions cm−2.
Low-energy electrons were used for charge compensation during
analysis. All spectra were acquired and processed with Surface Lab
software (version 7.0, ION-TOF GmbH, Münster, Germany).
2.5. Multivariate Analysis. The ToF-SIMS spectral data were
evaluated by multivariate analysis. The search peaks function in
Surface Lab software was used on spectra from each material and
region of interest (ROI) spectra obtained from macrophages and
bone. Peaks that had >100 counts, a signal to noise ratio of >3, and a
width of 0.8 Da were selected. In total, more than five replicate
measurements from each of the reference materials and six ROI
spectra from macrophages and bone were selected. The data set
included 330 positive ions that were subjected to principal component
analysis (PCA) in SIMCA (version 15.0, Umetrics, Umea, Sweden).
The spectra were pretreated by mean centering and Pareto scaling.
No peaks except [H]+, m/z 1, were eliminated from the PCA analysis.
3. RESULTS
3.1. Clinical Retrieval. The cranial explant is composed of
a CaP biomaterial with hexagonal-shaped tiles reinforced with
a medical-grade 23 titanium mesh (Figure 1A). Prior to
explantation, clinical CT revealed bone ingrowth and bone
formation on and inside the tiles and bridging bone formation
in the intertile spaces (Figure 1B). Perioperative gross
inspection, 31 months after implantation, revealed the
formation of normal vascularized bone and an implant that
was well-integrated with the recipient’s bone (Figure 1C). The
analysis was directed to the ROI between tiles where the new
bone had bridged the previously empty space (Figure 1D),
evident in both CT and perioperative observations, which was
confirmed by histology (Figure 1E). No tumor infiltration or
tumor-infiltrating lymphocytes were noted in the ROI.
3.2. Post-implantation Imaging of the CaP Implant.
3.2.1. Characterization of the Reference Materials. The
phase composition of the reference CaP materials was
quantified with XRD: the β-CPP was pure at 97% with 3%
impurity of β-TCP; β-TCP was pure at 97% with 2% impurity
of hydroxyapatite and 1% β-CPP; and monetite was pure at
97% with 2 and 1% impurity of β-TCP and β-CPP,
respectively. The XRD pattern for each present material
phase is depicted in Figure 2.
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The implant (CaP prior to implantation) showed a mixture
of CaPs: monetite (84%), β-TCP (9%), and β-calcium
pyrophosphate (β-CPP, 7%). Additionally, the reference
materials were analyzed with TOF-SIMS. Representative
mass spectra for the different CaP phases, monetite, β-TCP,
and β-CPP, can be seen in Figure S1. All CaP spectra appear
relatively similar with peaks from calcium oxide and calcium




3.3. Histology. Histological analysis verified the trans-
formation of the CaP into viable woven and lamellar bone with
apparent bone bridging between tiles (Figure 3). Bone had
formed directly on the CaP and infiltrated its porous structure.
Osteoblasts (Ob), osteoclasts (Ocl), osteocytes (OcY), and
material-filled macrophages (MFM) were detected. Macro-
phages were found within compartments with adipose tissue
and blood vessels surrounded by newly formed bone.
3.4. ToF-SIMS Analysis. The specific content of macro-
phages found in the CaP−Ti explant regarding the three CaP
phases, monetite, β-TCP, and β-CPP, was investigated. The
ROI selected was at the intertile spaces of the explant CaP tiles
(Figure 4), where bridging of tiles with newly formed bone was
observed and macrophages were commonly identified.
Figure 1. Clinically retrieved specimen. (A) Schematic overview of
the subject’s skull and implant prior to implantation. (B) CT scan
prior to implant retrieval. The dotted red line marks the location of
the histology section. (C) Perioperative image of the CaP−Ti-
reinforced implant. (D) Schematic overview of the position of the
histological section. (E) Histology section prior to staining with clear
bone bridging between the CaP tiles of the implant and after staining.
Illustration of the ROI selected for analysis (scale bar, 1 mm). The
dotted red square marks the ROI. Acronyms: CaP: calcium
phosphate, CaP−Ti: titanium-reinforced CaP cranial implant, NFB:
newly formed bone, RB: recipient bone, TM: temporal muscle, and
Ti: titanium.
Figure 2. Characterization of different phases. XRD patterns for pure
β-CPP, β-TCP, and monetite reference samples. The patterns
correspond to the PDF reference patterns for β-CPP (PDF# 04-
009-3876), β-TCP (PDF# 04-010-4348), and monetite (PDF# 04-
009-3755).
Figure 3. Macrophages within adipose compartments containing
blood vessels surrounded by the newly formed bone. Histological
image of the ROI (Figure 1E) in the intertile space of the retrieved
titanium-reinforced CaP cranial implant using modified Paragon.
Bone formation was registered on the CaP material with visible
osteocytes, osteoblasts, and osteoclasts. One osteoclast is observed
remodeling the newly formed bone. MFMs were found within adipose
compartments containing blood vessels surrounded by newly formed
bone. Acronyms: AdT: adipose tissue, BV: blood vessel, CaP: calcium
phosphate, MFM: material-filled macrophages, NFB: newly formed
bone, RB: recipient bone, Ob: osteoblasts, Ocl: osteoclasts, OcY:
osteocytes, RBC: red blood cells, and Ti: titanium. (Scale bar, 100
μm).
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Histology (Figure 4A,C) was compared to ToF-SIMS 2D
total ion images (Figure 4B). Similar bone morphology and
composition were visualized with ToF-SIMS, as was seen in
histology. Macrophages in the explanted material identified by
histological screening of the unstained material (Figure
4A,D,F) and, subsequently, of the stained sample (Figure
4C,E,F) were analyzed by ToF-SIMS 3D imaging, as shown in
Figure 4G. Higher magnification of macrophages filled with the
CaP material in the ROI can be seen in Figure 4F. The MFMs
previously detected showed ion signals for the nucleus
([C8H10NO]
+) and lipids ([C5H9]
+ and [C5H15PNO4]
+)
associated with cell membranes distinctive for cells (Figure
4G and additional information in Figure S3). These data
corroborate with typical morphology and cell dimensions of
macrophages from histological findings.
The macrophage content was isolated by ROI analysis of the
3D chemical imaging data and compared to spectra from the
CaP phases, monetite, β-TCP, and β-CPP, and ROIs from the
bone and CaP in the implants after PCA (Figure 5). All
components and individual loadings are shown in the
Supporting Information, Figure S2.
Principal component t[1] mostly captures differences in the
salt content, that is, m/z 22.9 and 38.9, reflecting the
differences between implanted (organic and inorganic) versus
non-implanted materials (inorganic), as shown in Figure 5A.
As can be seen in the x-axis (Figure 5B), component t[2]
reveals more relevant information where characteristic peaks
from, for example, CaxPy can be found. Therefore, the results
are presented in scores (Figure 5B) and loading plots (Figure
5D) associated with components t[2] and t[3]. The score plot
of t[2] versus t[3] reveals high similarity between the different
Figure 4. Histology and ToF-SIMS imaging of the intertile space. (A)
Light microscopy image of the intertile space in the unstained sample
(scale bar, 100 μm). (B) Corresponding TOF-SIMS total ion images
(field view of 200 × 200 μm). (C) Light microscopy image of the
intertile space after modified Paragon staining (scale bar, 100 μm).
(D) Magnification of the histology sample with MFM in the ROI
(40× magnification) and (E) stained histology. (F) Higher
magnification of macrophages filled with the CaP material in the
ROI. (G) ToF-SIMS ion overlay image (200 × 200 μm2) showing cell
content as highlighted by signals of Ca2PO4 and Ca3PO5 in red and
DNA marker (C8H10NO) at m/z 136.1 in green superimposed on the
ion signal from a general lipid fragment from cell membranes C5H9 in
blue. The dashed red line represents the ROI. Acronyms: CaP:
calcium phosphate, MFM: material-filled macrophages, NFB: newly
formed bone, OcY: osteocytes, RA: resin artifact, and RBC: red blood
cells.
Figure 5. Multivariate analysis (PCA) comparing macrophage
content with spectra from the different calcium phosphate (CaP)
phases and bone and CaP in the implants. (A) 1D score plot of t[1]
showing the implanted (organic and inorganic) vs non-implanted
materials (inorganic). Percent variation captured by t[1] 0.426%.
Ellipse: Hotelling’s T2 (95%). (B) Score biplot from t[2] vs t[3]
highlighting sample grouping and showing the main similarity
between the macrophage content and β-CPP. Circle: Hotelling’s T2
(95%). (C) Corresponding load plot for t[2] vs t[3]. Gray: monetite,
Yellow: β-CPP, Blue: β-TCP, Purple: macrophage cell content,
Orange: bone in the implant, and Green: CaP from the implant.
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CaP phases monetite (gray) and β-CPP (yellow) and the CaP
reference (green) except the β-TCP phase (blue) (Figure 5B).
The macrophage content (purple) can be seen to be mostly
similar to that of the raw material β-CPP followed by monetite,
while the bone sample (orange) lies further away from the
macrophages and therefore is less similar to the content of the
macrophages.
The PCA analysis could be confirmed by studying the
individual spectra (Figure S1). The material trapped inside the
macrophages (described in the histological findings) contained
peaks matching the pattern from both monetite and β-CPP,
with the main cell content being mostly similar to that of β-
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Ca PO Ca PO
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+
species inside the cells and compared to
different CaP phases (β-CPP, β-TCP, and monetite) and
samples of human tissue cranial explants (i.e., CaP and bone).
The ratios are provided in Table 1.
Furthermore, ToF-SIMS 3D imaging corroborated that (i)
the β-CPP signal was from the intracellular content rather than
a surface phenomenon and (ii) the β-CPP signal is consistent
throughout the cell (Figure 6). Additional results can be found
in the Supporting Information (Figure S3).
4. DISCUSSION
Several studies have revealed the presence of macrophages
filled with the CaP material, which has been shown to play a
role in bone formation, independent of the implantation time
and location of the defect.2−4,6,8,22,25,42−44 In addition, it has
always been assumed that the intracellular content of these
macrophages is of the homogenous composition of the
biomaterial chosen or accessible to cells in the biological
milieu described. In this study, by applying a targeted 2D/3D
ToF-SIMS and multivariate analysis in combination with
conventional histology, we investigated the cell content of the
macrophages identified in a human cranial explant.
The CaP explant investigated contains monetite (84%), β-
TCP (9%), and β-CPP (7%); it could thus be assumed that a
similar material composition might be found within the
macrophages. However, based on the quantity of each CaP
phase and its dissolution profiles in aqueous solutions and the
cell digestion process, we hypothesized that the material found
within the identified macrophages would be mostly β-CPP
given that 31 months had passed since implantation.
By applying 2D/3D ToF-SIMS imaging and multivariate
analysis, we confirmed the macrophage content to be most
similar to that of β-CPP and, to a lesser extent, monetite.
Noteworthy is that the implant contains only 6% β-CPP in
contrast to 84% monetite, and still, β-CPP was the main phase
found intracellularly. This finding follows the passive solubility
trends between the different CaP phases that we assumed
earlier, that is, monetite is the most soluble phase followed by
β-TCP and ending with the almost insoluble phase β-CPP.45,46
This remaining phase, β-CPP, seems to resist complete
digestion by macrophages even after 31 months, which
coincides with the study by Wu and Uskokovic ́47 They
showed in vitro that β-CPP was substantially more retained by
phagocytic cells as compared to amorphous CaP, hydrox-
yapatite, and monetite when supplied individually. Further-
more, they observed that the cells consumed more of the
monetite powder. The biological processes of phagocytic and
enzymatic degradation, local variations in acidity, wettability
and/or oxidative degradation are factors that contribute to the
fate of CaPs inside the macrophages.15,48−50 CaP hydrolysis
can be facilitated with a more acidic milieu and the presence of
digestive enzymes, which are characteristic settings found
inside the organelles involved in the phagocytosis process
within cells, such as macrophages.45,46,51 This pH variation will
impact the dissolution of the different CaP phases and,
consequently, the amount of the material found intracellularly.
Despite monetite being the most soluble phases at
physiological pH,52 the substantial amount (84%) present in
the CaP explant will mostly determine that monetite particles
will be present in cells to a higher degree and more prone than
other phases to be ingested by macrophages, which might
explain the remaining presence of monetite in our findings.
Although β-CPP and β-TCP share similar proportions in the
implant (β-TCP, 9%, and β-CPP, 7%), β-TCP is less likely to
be found due to the higher solubility compared to that of β-
CPP.45,46 Furthermore, when an oxidative degradation
environment is present (i.e., in the presence of reactive
oxidative species), either in low pH or not, some materials can
also be susceptible to higher solubility and/or chemical bond
cleavage.48
The byproducts generated during the material phagocytosis
can be either used or offloaded by macrophages to maintain a
healthy metabolism.53 For instance, monetite, when inside the
macrophages and under acidic conditions, will degrade to its
hydrolysis products, that is, calcium (Ca2+) and phosphate
(HPO4
2−) ions, which can be used in a wide range of biological
processes (cell division, growth, development, enzyme
activation, etc.).54,55 In part, this difference between the
calcium and phosphate ions in the non-implanted and
implanted materials (inorganic) is captured by the first
component of the PCA model. Additionally, the first
component differentiates the presence or absence of an
organic source, that is, implanted or not. If not used by cells,
the calcium phosphate bioproducts can be offloaded and might
re-precipitate into the most stable CaP.
The ToF-SIMS analysis allowed us additionally to
distinguish the overall tissue structure of the sample with
similar morphological and compositional patterns, as described
in histology. The histological analysis clearly showed the
presence of the transformation of the CaP into a viable woven
and lamellar bone. Additionally, it revealed the presence of
different cells, osteoblasts, osteoclasts, osteocytes, and macro-
phages filled with the CaP material in the vicinity of the new
bone−implant interface.2−4,6,8,22,25,42,43
Overall, ToF-SIMS offers a unique way of probing the cell
content in situ in an explant, without any need for further
sample preparation. Even though ToF-SIMS has been used to
Table 1. Ratio between P O PO H
Ca PO Ca PO
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probe cell content in cultured osteoblast-like cells,30 in bone-
biomaterial interphases,56−31 and in other types of tissues such
as muscle and lung biopsies,58 it has not yet been utilized to
identify cell content in explants or implant surroundings.
One limitation of ToF-SIMS is that it is a surface-sensitive
method, which requires pure samples without surface
contamination. This can in part, as was done in this study,
be addressed by depth profiling and 3D ToF-SIMS analysis,
where chemical information from not only the surface but also
the depth of a sample/cell is taken into account. The data
obtained are analyzed semi-quantitatively with the need for
multivariate analysis to interpret the data. However, ToF-SIMS
can be used without any a priori knowledge of the sample or
the need for any specific tissue and/or material stains or labels.
Using labels always carries a risk that not only the structure
and/or function of the material under study but also the
fundamental biological answer is altered. Given the study
aimed to investigate whether ToF-SIMS would allow for the
identification of the macrophage content, known variabilities
affecting bone metabolism, such as gender, health status, and
age,59,60 were not taken into account. To the best of our
knowledge, this study is the first to uncover the content of
macrophages directly on a human explant.
Future studies should explore a wider range of calcium
phosphate biomaterials to allow for both organic and inorganic
target comparisons of various MFMs found in vivo. In addition,
a larger sample size would allow for within and between cohort
variations to be studied.
In summary, the 2D/3D ToF-SIMS analysis of macrophages
from a human cranial explant revealed β-CPP to be the main
intracellular phase when exposed to a triphasic CaP material.
Furthermore, the ToF-SIMS 3D analysis showed that the cell
content was distributed throughout the whole of the
macrophage, which ruled out the possibility of this being a
surface phenomenon or an artifact of analyzing content outside
the cells.
5. CONCLUSIONS
In this study, we demonstrate the feasibility to employ ToF-
SIMS to uncover human macrophage cellular content during
material resorption. The combination of 2D/3D ToF-SIMS
and histology was applied to elucidate the distinct CaP phases
in macrophages from a human multiphasic CaP explant,
demonstrating pyrophosphate (β-CPP) to be the main phase
present. The ability to distinguish and localize multiple CaP
phases on an intracellular level opens up the possibilities to




The Supporting Information is available free of charge at
https://pubs.acs.org/doi/10.1021/acsabm.1c00513.
TOF-SIMS spectra from reference materials and im-
plants; full results from a PCA analysis based on the
positive ion-mode ToF-SIMS data; and complementary
TOF-SIMS ion images (PDF)
Figure 6. Distribution of CaxPy species in the ROI. (A) ToF-SIMS 2D image of the ROI containing macrophages showing the distribution of
[Ca2PO4]
+ and [Ca3PO5]
+ in red and [C5H9]
+ in blue. (B) ToF-SIMS 3D iso-surface renderings of the area with a general lipid signal from (B)
C5H9 in blue and (C) Ca2PO4 in red. (D) 3D overlay showing the 3D distribution of Ca2PO4 in red and C5H9 in blue highlighting the distribution
of the macrophage cell content in the depth of the cells matching with (E) unstained histology magnification. Depth of analysis is approx. 200 nm.
Acronym: RA: resin artifact.
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